期刊文献+

miR-206在血管瘤患儿外周血清中的表达及其与普萘洛尔疗效的相关性 被引量:1

Expression of miR-206 in peripheral blood of hemangioma children and its correlation with the efficacy of propranolol
原文传递
导出
摘要 目的探讨微小RNA-206(micro RNA-206,miR-206)在血管瘤患儿外周血中的表达及其与普萘洛尔疗效的相关性。方法检测45例接受普萘洛尔治疗的血管瘤患儿外周血清中miR-206表达水平,将患儿按照miR-206均值分为高表达组(n=19)和低表达组(n=26),比较两组临床特征;将患儿根据治疗6个月后的疗效分为疗效良好组(n=29)和疗效一般组(n=16),采用Logistic回归分析miR-206是否是疗效的影响因素,采用ROC曲线评价miR-206对普萘洛尔治疗血管瘤疗效的预测价值。结果高表达组在<6月龄、增生期、瘤体面积≥10 cm2的患儿比例显著低于低表达组(分别χ^(2)=4.664、7.207、8.927,P=0.031、0.007、0.012);治疗后患儿miR-206表达水平(3.25±0.64)显著高于治疗前(2.12±0.41)水平(t=9.973,P<0.05);普萘洛尔治疗6个月后,疗效良好组患儿治疗前miR-206高表达比例(24.1%)显著低于疗效一般组(75.0%)(χ^(2)=10.934,P=0.001);治疗前miR-206高表达是普萘洛尔治疗血管瘤患儿疗效不良的危险因素[OR(95%CI)=6.423(1.436~28.731),P=0.015];ROC曲线分析显示,血清miR-206预测普萘洛尔治疗血管瘤疗效的ROC曲线下面积为0.798,敏感性为0.83,特异性为0.75。结论血清miR-206表达与血管瘤患儿年龄、是否增生期及瘤体面积有关,这可能是预测婴幼儿血管瘤普萘洛尔疗效的重要指标之一。 Objective To investigate the expression of microRNA(miR)-206 in the peripheral serum of hemangioma children and its correlation with curative effect of propranolol treatment.Methods The expression of miR-206 in serum of 45 hemangiomas children treated with propranolol treatment was detected.The children were divided into the high expression group(n=19)and the low expression group(n=26)according to the mean value of miR-206,and the clinical characteristics of the two groups were compared;The children were divided into the good efficacy group(n=29)and general efficacy group(n=16)according to the efficacy after 6 months of treatment.Logistic regression was used to analyze whether miR-206 was an influencing factor of efficacy,and ROC curve was used to evaluate the predictive value of miR-206.Results The proportion of children<6 months,in hyperplasia stage and with tumor area≥10 cm2 in the high expression group was significantly lower than that in the low expression group(χ^(2)=4.664,7.207,8.927,P=0.031,0.007,0.012,respectively).The miR-206 level after treatment(3.25±0.64)was significantly higher than that before treatment(2.12±0.41,t=9.973,P<0.05).After six months of propranolol treatment,the proportion of high expression of miR-206 before treatment in the good efficacy group(24.1%)was significantly lower than that in the general efficacy group(75.0%,χ^(2)=10.934,P=0.001).High expression of miR-206 before treatment was a risk factor for poor curative effect of propranolol in hemangioma children[CI(95%CI)=6.423(1.436~28.731),P=0.015];ROC curve analysis showed that the area under ROC curve of miR-206 for predicting the efficacy of propranolol was 0.798,the sensitivity was 0.83,and the specificity was 0.75.Conclusion The expression of serum miR-206 was correlated with age,proliferative stage and tumor area and may be one of the important indicators for predicting propranolol effect in children with hemangioma.
作者 狄奇 李三林 张靖 于春欣 刘景 申刚 Di Qi;Li Sanlin;Zhang Jing;Yu Chunxin;Liu Jing;Shen Gang(Children′s Hospital Capital Institute of Pediatrics,Beijing 100020,China;Guangzhou Women and Children′s Medical Center,Guangzhou 510623,China;Children′s Hospital Affiliated to Zhengzhou University,Henan Provincial Children′s Hospital,Zhengzhou 450000,China)
出处 《国际儿科学杂志》 2021年第10期705-709,共5页 International Journal of Pediatrics
基金 河南省医学科技攻关计划联合共建项目(LHGJ20190950)。
关键词 婴幼儿 血管瘤 普萘洛尔 微小RNA-206 Infant Hemangioma Propranolol MicroRNA-206
  • 相关文献

参考文献8

二级参考文献39

共引文献73

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部